Tatsis Ourania

EVP, Chief Reg. & Quality Off.VERTEX PHARMACEUTICALS INC / MA (VRTX) · full profile →Form 4 · filed Feb 19, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$472K
Net Open-Market Flow
-$472K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 18, 2026Sell(S)368$473.68$174K49K
Feb 17, 2026Sell(S)609$489.46$298K49K
Feb 17, 2026Tax withholding(F)2K$483.75$1.1M50K
Feb 17, 2026Grant(A)6K$052K

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000875320-26-000098) within minutes of acceptance. Every field above traces to the original document. Verify it directly: